[Congressional Record Volume 170, Number 140 (Tuesday, September 10, 2024)]
[House]
[Page H5109]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                  RAISING CONCERNS WITH BIOSECURE BILL

  (Mr. AUCHINCLOSS asked and was given permission to address the House 
for 1 minute.)
  Mr. AUCHINCLOSS. Mr. Speaker, I rise today to outline my concerns 
with H.R. 8333, the BIOSECURE Act, which I voted against last night.
  This bill, though well-intentioned, is poorly drafted and shows the 
deficit of proper process. The BIOSECURE Act would only apply to 
contracts subject to the Federal Acquisition Regulation System. That is 
the Department of Defense and the Department of Veterans Affairs.
  This means that while Medicare and commercial-plan beneficiaries 
could access the drugs comprehended by the BIOSECURE Act, veterans and 
servicemembers could be alienated from treatments and cures that are 
available to other Americans. This bifurcation is not only unfair, but 
it renders the disincentive to biotechs ineffective.
  This legislation also fails to provide due process so that Congress 
is not veering into potential bill of attainder challenges. In its 
form, the bill is not fit to function and makes no attempt to support a 
domestic CDMO or CRO industry.

                          ____________________